Extract notice to the Minister

Mint-Imatinib

Common name / Subject : imanitib (mésylate d')
Name of the manufacturer : Mint
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription -Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on September 30, 2020

Subscribe to our newsletter now

Subscription